Search results
Results from the WOW.Com Content Network
Tabernanthe iboga (iboga) is an evergreen rainforest shrub native to Central Africa. A member of the Apocynaceae family indigenous to Gabon, the Democratic Republic of Congo, and the Republic of Congo, it is cultivated across Central Africa for its medicinal and other effects.
Ibogaine has potential for adverse interactions with other psychedelic agents and prescription drugs. [15] [17] Death may occur with the use of ibogaine, [17] especially if consumed with opioids or in people with existing morbidities, such as cardiovascular disease or neurological disorders. [15]
In November 2020, the U.S. Food and Drug Administration approved lonafarnib, which helps prevent buildup of defective progerin and similar proteins. [49] A clinical trial in 2018 points to significantly lower mortality rates – treatment with lonafarnib alone compared with no treatment (3.7% vs. 33.3%) – at a median post-trial follow-up time ...
The most important aspect of a virus is not whether it’s technically new or simply a variant. It’s the danger that virus poses. Body work: When does a virus grow so much that it gets a new name?
Vaccines are another method of virotherapy that use attenuated or inactivated viruses to develop immunity to disease. An attenuated virus is a weakened virus that incites a natural immune response in the host that is often undetectable. The host also develops potentially life-long immunity due to the attenuated virus's similarity to the actual ...
A new drug increased the lifespans of mice by almost 25%, decreased deaths related to cancer and other diseases, igniting hope for slowing aging in humans. New drug helps fight typical signs of ...
A human pathogen is a pathogen (microbe or microorganism such as a virus, bacterium, prion, or fungus) that causes disease in humans.. The human physiological defense against common pathogens (such as Pneumocystis) is mainly the responsibility of the immune system with help by some of the body's normal microbiota.
Researchers have found that a novel drug molecule may fight the development of early-onset Parkinson’s disease in younger people. The new compound, BIO-2007817, is from the family of ...